Genomic technologies have opened the door to medicine that takes into account the unique clinical, genetic, genomic and environmental characteristics of individuals.   This session will explore current research in personalized medicine, its application to clinical practice and commercial opportunities and challenges in the near and mid-term.  Don't miss this all-star panel of researchers, practitioners and investors as they provide their take on the state of this distinctly 21st century science. 

Panel members will include:

Richard Lifton, M.D., Ph.D., Sterling Professor of Genetics and Professor of Medicine (Nephrology); Chair, Department of Genetics; Investigator, Howard Hughes Medical Institute
Thomas Lynch, M.D., Director, Smilow Cancer Center at Yale New Haven Hospital
Jonathan Rothberg, Ph.D., Founder, CEO and Chairman, Ion Torrent Systems, Life Technologies
Timothy Shannon, M.D., Partner, Canaan Partners
Moderator: Paul Pescatello, President and CEO, CURE

As always, CVG programs include ample time for networking, both before and after the presentation.

Agenda:

4:30- 5:00 PM Registration and Networking
5:00 - 6:00 PM Panel Discussion
6:00 - 7:00 PM Refreshments and Networking 

Event presenters: